New Key Statistics Module, Z-Score and F-Score
NAS:EYPT Key Ratios
Market Cap $ M | 629.70 |
Enterprise Value $ M | 334.97 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.23 |
Price/Sales | 10.29 |
Price/Free Cash Flow | 335.83 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 46.00 |
EPS (TTM) $ | -1.82 |
Beneish M-Score | -3.71 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 27.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.82 |
EV-to-EBITDA | -4.85 |
PEG | -- |
Shares Outstanding M | 52.08 |
Net Margin (%) | -153.84 |
Operating Margin % | -163.13 |
Pre-tax Margin (%) | -153.66 |
Quick Ratio | 5.39 |
Current Ratio | 5.45 |
ROA % (ttm) | -34.51 |
ROE % (ttm) | -63.55 |
ROIC % (ttm) | -200.03 |
Dividend Yield % | -- |
Altman Z-Score | 1.76 |
EYPT Number of Guru Trades
EYPT Volume of Guru Trades
Gurus Latest Trades with NAS:EYPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:EYPT is held by these investors
Total 1
EyePoint Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:EYPT
Total 0- 1